Agilent Technologies (A) Cash from Investing Activities (2009 - 2026)
Agilent Technologies (A) posted quarterly Cash from Investing Activities of -$77.0 million for Q2 2026, up 32.46% YoY from -$58.1 million in Q2 2025, and up 17.2% sequentially from -$93.0 million in Q1 2026.
Agilent Technologies (A) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Agilent Technologies has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$77.0 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 32.46% year-over-year to -$77.0 million; the TTM figure through Apr 2026 stood at -$356.0 million (up 71.79% YoY), while the FY2025 annual figure was -$394.0 million, up 68.68% from the prior year.
- Cash from Investing Activities grew to -$77.0 million in Q2 2026, from -$93.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for A reached as high as -$40.0 million in Q4 2023 and fell as low as -$954.0 million in Q4 2024.
- The 5-year median for Cash from Investing Activities is -$93.5 million (2025), against an average of -$137.2 million.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities slumped 2285.0% — and 2025, when it jumped 90.57%.
- A 5-year view of Cash from Investing Activities shows it stood at -$110.0 million in 2022, then soared by 63.64% to -$40.0 million in 2023, then tumbled by 2285.0% to -$954.0 million in 2024, then jumped by 90.57% to -$90.0 million in 2025, then advanced by 14.44% to -$77.0 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$77.0 million, -$93.0 million, and -$90.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -77.00 Mn |
| Apr 30, 2026 | -77.00 Mn |
| Jan 31, 2026 | -93.00 Mn |
| Jan 31, 2026 | -93.00 Mn |
| Oct 31, 2025 | -90.00 Mn |
| Oct 31, 2025 | -90.00 Mn |
| Jul 31, 2025 | -96.00 Mn |
| Jul 31, 2025 | -96.00 Mn |
| Apr 30, 2025 | -114.00 Mn |
| Apr 30, 2025 | -114.00 Mn |
| Jan 31, 2025 | -94.00 Mn |
| Jan 31, 2025 | -94.00 Mn |
| Oct 31, 2024 | -954.00 Mn |
| Oct 31, 2024 | -954.00 Mn |
| Jul 31, 2024 | -100.00 Mn |
| Jul 31, 2024 | -100.00 Mn |
| Apr 30, 2024 | -109.00 Mn |
| Apr 30, 2024 | -109.00 Mn |
| Jan 31, 2024 | -95.00 Mn |
| Jan 31, 2024 | -95.00 Mn |